Previous Article Due Diligence Policy Next Article Board of Directors Transparency and Ethical Business Practice We know that our patients, and all stakeholders seek assurance that Teva acts lawfully, ethically and responsibly, and increasingly, stakeholders are transparent about our business practices and not only our medicines. Share on Facebook Share on LinkedIn Share on Twitter ✉ We aim to maintain the trust of our stakeholders in our company and our people by upholding high standards of responsible and ethical behavior. This includes maintaining a culture of ethics and compliance and ensuring our approach is embedded throughout our supply chain. Each year, we aim to increase the transparency of our practices to ensure all our stakeholders can make informed decisions. EFPIA Disclosure 2018As noted in this 2018 self-certification letter, transparent collaboration with healthcare professionals and healthcare organizations is extremely important to Teva. Below is a list of disclosures per country, under the EFPIA’s transparency framework (Disclosure Code and guidelines) for 2018: Austria Belgium Bulgaria Croatia Czech Republic Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Lithuania Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden - TevaActavisSwitzerland - Teva Pharma in GermanTeva Pharma in FrenchMepha Pharma in GermanMepha Pharma in FrenchUnited Kingdom
We aim to maintain the trust of our stakeholders in our company and our people by upholding high standards of responsible and ethical behavior. This includes maintaining a culture of ethics and compliance and ensuring our approach is embedded throughout our supply chain. Each year, we aim to increase the transparency of our practices to ensure all our stakeholders can make informed decisions. EFPIA Disclosure 2018As noted in this 2018 self-certification letter, transparent collaboration with healthcare professionals and healthcare organizations is extremely important to Teva. Below is a list of disclosures per country, under the EFPIA’s transparency framework (Disclosure Code and guidelines) for 2018: Austria Belgium Bulgaria Croatia Czech Republic Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Lithuania Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden - TevaActavisSwitzerland - Teva Pharma in GermanTeva Pharma in FrenchMepha Pharma in GermanMepha Pharma in FrenchUnited Kingdom